Clal Biotechnology Industries Ltd
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to i… Read more
Clal Biotechnology Industries Ltd (CBI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.033x
Based on the latest financial reports, Clal Biotechnology Industries Ltd (CBI) has a cash flow conversion efficiency ratio of -0.033x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.06 Million) by net assets (ILA32.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Clal Biotechnology Industries Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Clal Biotechnology Industries Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Clal Biotechnology Industries Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Clal Biotechnology Industries Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZeU Technologies Inc
PINK:ZEUCF
|
0.000x |
|
Emeis
F:OPA1
|
N/A |
|
Clearday Inc
PINK:CLRD
|
0.010x |
|
KIRIN HOLDINGS - Dusseldorf Stock Exchang
DU:KIR
|
0.043x |
|
R STAHL N (RSL2.SG)
STU:RSL2
|
-0.003x |
|
PERSIMMON PLC - Dusseldorf Stock Exchang
DU:OHP
|
N/A |
|
Sparinvest Globale Fokusaktier KL A
CO:SPIGFA
|
N/A |
|
MAIRE TECNIMONT
BE:3OY1
|
0.051x |
Annual Cash Flow Conversion Efficiency for Clal Biotechnology Industries Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Clal Biotechnology Industries Ltd from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA46.16 Million | ILA-6.48 Million | -0.140x | -100.12% |
| 2023-12-31 | ILA121.41 Million | ILA-8.51 Million | -0.070x | +82.79% |
| 2022-12-31 | ILA144.90 Million | ILA-59.04 Million | -0.407x | -233.60% |
| 2021-12-31 | ILA338.37 Million | ILA-41.33 Million | -0.122x | -88.87% |
| 2020-12-31 | ILA513.79 Million | ILA-33.23 Million | -0.065x | -219.11% |
| 2019-12-31 | ILA497.85 Million | ILA27.03 Million | 0.054x | +154.16% |
| 2018-12-31 | ILA867.62 Million | ILA-86.98 Million | -0.100x | +11.36% |
| 2017-12-31 | ILA808.20 Million | ILA-91.41 Million | -0.113x | +24.44% |
| 2016-12-31 | ILA752.50 Million | ILA-112.63 Million | -0.150x | -11.24% |
| 2015-12-31 | ILA1.09 Billion | ILA-147.00 Million | -0.135x | -46.12% |
| 2014-12-31 | ILA1.26 Billion | ILA-115.95 Million | -0.092x | +14.64% |
| 2013-12-31 | ILA1.38 Billion | ILA-148.98 Million | -0.108x | -85.31% |
| 2012-12-31 | ILA1.40 Billion | ILA-81.22 Million | -0.058x | +37.01% |
| 2011-12-31 | ILA1.11 Billion | ILA-102.45 Million | -0.092x | -1.22% |
| 2010-12-31 | ILA1.23 Billion | ILA-111.93 Million | -0.091x | +17.70% |
| 2009-12-31 | ILA782.91 Million | ILA-86.86 Million | -0.111x | +41.91% |
| 2008-12-31 | ILA274.45 Million | ILA-52.41 Million | -0.191x | -25.63% |
| 2007-12-31 | ILA309.49 Million | ILA-47.05 Million | -0.152x | +24.93% |
| 2006-12-31 | ILA116.28 Million | ILA-23.55 Million | -0.203x | -- |